PMC:7243778 / 28602-29684 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"714","span":{"begin":232,"end":236},"obj":"Gene"},{"id":"715","span":{"begin":790,"end":791},"obj":"Gene"},{"id":"716","span":{"begin":29,"end":39},"obj":"Species"},{"id":"717","span":{"begin":76,"end":84},"obj":"Species"},{"id":"718","span":{"begin":88,"end":98},"obj":"Species"},{"id":"719","span":{"begin":442,"end":450},"obj":"Species"},{"id":"720","span":{"begin":511,"end":521},"obj":"Species"},{"id":"721","span":{"begin":603,"end":611},"obj":"Species"},{"id":"722","span":{"begin":658,"end":668},"obj":"Species"},{"id":"723","span":{"begin":725,"end":735},"obj":"Species"},{"id":"724","span":{"begin":803,"end":813},"obj":"Species"},{"id":"725","span":{"begin":943,"end":951},"obj":"Species"},{"id":"726","span":{"begin":1058,"end":1066},"obj":"Species"},{"id":"727","span":{"begin":1071,"end":1081},"obj":"Species"},{"id":"728","span":{"begin":142,"end":147},"obj":"Species"},{"id":"729","span":{"begin":821,"end":830},"obj":"Disease"}],"attributes":[{"id":"A714","pred":"tao:has_database_id","subj":"714","obj":"Gene:59272"},{"id":"A715","pred":"tao:has_database_id","subj":"715","obj":"Gene:43740568"},{"id":"A716","pred":"tao:has_database_id","subj":"716","obj":"Tax:2697049"},{"id":"A717","pred":"tao:has_database_id","subj":"717","obj":"Tax:694009"},{"id":"A718","pred":"tao:has_database_id","subj":"718","obj":"Tax:2697049"},{"id":"A719","pred":"tao:has_database_id","subj":"719","obj":"Tax:694009"},{"id":"A720","pred":"tao:has_database_id","subj":"720","obj":"Tax:2697049"},{"id":"A721","pred":"tao:has_database_id","subj":"721","obj":"Tax:694009"},{"id":"A722","pred":"tao:has_database_id","subj":"722","obj":"Tax:2697049"},{"id":"A723","pred":"tao:has_database_id","subj":"723","obj":"Tax:2697049"},{"id":"A724","pred":"tao:has_database_id","subj":"724","obj":"Tax:2697049"},{"id":"A725","pred":"tao:has_database_id","subj":"725","obj":"Tax:694009"},{"id":"A726","pred":"tao:has_database_id","subj":"726","obj":"Tax:694009"},{"id":"A727","pred":"tao:has_database_id","subj":"727","obj":"Tax:2697049"},{"id":"A728","pred":"tao:has_database_id","subj":"728","obj":"Tax:9606"},{"id":"A729","pred":"tao:has_database_id","subj":"729","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T131","span":{"begin":154,"end":162},"obj":"Body_part"},{"id":"T132","span":{"begin":263,"end":275},"obj":"Body_part"},{"id":"T133","span":{"begin":263,"end":267},"obj":"Body_part"},{"id":"T134","span":{"begin":647,"end":654},"obj":"Body_part"},{"id":"T135","span":{"begin":792,"end":799},"obj":"Body_part"},{"id":"T136","span":{"begin":881,"end":903},"obj":"Body_part"},{"id":"T137","span":{"begin":891,"end":903},"obj":"Body_part"}],"attributes":[{"id":"A131","pred":"fma_id","subj":"T131","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A132","pred":"fma_id","subj":"T132","obj":"http://purl.org/sig/ont/fma/fma67653"},{"id":"A133","pred":"fma_id","subj":"T133","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A134","pred":"fma_id","subj":"T134","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A135","pred":"fma_id","subj":"T135","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A136","pred":"fma_id","subj":"T136","obj":"http://purl.org/sig/ont/fma/fma70573"},{"id":"A137","pred":"fma_id","subj":"T137","obj":"http://purl.org/sig/ont/fma/fma62870"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T127","span":{"begin":29,"end":37},"obj":"Disease"},{"id":"T128","span":{"begin":76,"end":84},"obj":"Disease"},{"id":"T129","span":{"begin":88,"end":96},"obj":"Disease"},{"id":"T130","span":{"begin":442,"end":450},"obj":"Disease"},{"id":"T131","span":{"begin":511,"end":519},"obj":"Disease"},{"id":"T132","span":{"begin":603,"end":611},"obj":"Disease"},{"id":"T133","span":{"begin":658,"end":666},"obj":"Disease"},{"id":"T134","span":{"begin":725,"end":733},"obj":"Disease"},{"id":"T135","span":{"begin":803,"end":811},"obj":"Disease"},{"id":"T136","span":{"begin":821,"end":830},"obj":"Disease"},{"id":"T137","span":{"begin":943,"end":951},"obj":"Disease"},{"id":"T138","span":{"begin":1058,"end":1066},"obj":"Disease"},{"id":"T139","span":{"begin":1071,"end":1079},"obj":"Disease"}],"attributes":[{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A129","pred":"mondo_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A130","pred":"mondo_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A131","pred":"mondo_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A132","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A133","pred":"mondo_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A134","pred":"mondo_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A135","pred":"mondo_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A136","pred":"mondo_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A137","pred":"mondo_id","subj":"T137","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A138","pred":"mondo_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T334","span":{"begin":0,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T335","span":{"begin":6,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T336","span":{"begin":62,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T337","span":{"begin":99,"end":102},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T338","span":{"begin":142,"end":147},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T339","span":{"begin":185,"end":192},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T340","span":{"begin":263,"end":267},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T341","span":{"begin":307,"end":315},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T342","span":{"begin":428,"end":430},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T343","span":{"begin":428,"end":430},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T344","span":{"begin":454,"end":456},"obj":"http://purl.obolibrary.org/obo/CLO_0001627"},{"id":"T345","span":{"begin":556,"end":560},"obj":"http://purl.obolibrary.org/obo/CLO_0001165"},{"id":"T346","span":{"begin":589,"end":591},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T347","span":{"begin":589,"end":591},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T348","span":{"begin":711,"end":713},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T349","span":{"begin":711,"end":713},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T350","span":{"begin":744,"end":745},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T351","span":{"begin":761,"end":763},"obj":"http://purl.obolibrary.org/obo/CLO_0001627"},{"id":"T352","span":{"begin":914,"end":916},"obj":"http://purl.obolibrary.org/obo/CLO_0001627"},{"id":"T353","span":{"begin":952,"end":954},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T354","span":{"begin":952,"end":954},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T161","span":{"begin":17,"end":24},"obj":"Chemical"},{"id":"T162","span":{"begin":428,"end":430},"obj":"Chemical"},{"id":"T163","span":{"begin":589,"end":591},"obj":"Chemical"},{"id":"T164","span":{"begin":647,"end":654},"obj":"Chemical"},{"id":"T165","span":{"begin":711,"end":713},"obj":"Chemical"},{"id":"T166","span":{"begin":752,"end":759},"obj":"Chemical"},{"id":"T167","span":{"begin":792,"end":799},"obj":"Chemical"},{"id":"T168","span":{"begin":843,"end":850},"obj":"Chemical"},{"id":"T169","span":{"begin":952,"end":954},"obj":"Chemical"}],"attributes":[{"id":"A161","pred":"chebi_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A162","pred":"chebi_id","subj":"T162","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A163","pred":"chebi_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A164","pred":"chebi_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A165","pred":"chebi_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A166","pred":"chebi_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/CHEBI_53000"},{"id":"A167","pred":"chebi_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A168","pred":"chebi_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/CHEBI_53000"},{"id":"A169","pred":"chebi_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T22","span":{"begin":1024,"end":1049},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T23","span":{"begin":1024,"end":1049},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T24","span":{"begin":1024,"end":1049},"obj":"http://purl.obolibrary.org/obo/GO_0002443"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T4","span":{"begin":556,"end":560},"obj":"GlycoEpitope"}],"attributes":[{"id":"A4","pred":"glyco_epitope_db_id","subj":"T4","obj":"http://www.glycoepitope.jp/epitopes/AN0438"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}

{"project":"LitCovid-sentences","denotations":[{"id":"T224","span":{"begin":0,"end":57},"obj":"Sentence"},{"id":"T225","span":{"begin":58,"end":137},"obj":"Sentence"},{"id":"T226","span":{"begin":138,"end":398},"obj":"Sentence"},{"id":"T227","span":{"begin":399,"end":522},"obj":"Sentence"},{"id":"T228","span":{"begin":523,"end":669},"obj":"Sentence"},{"id":"T229","span":{"begin":670,"end":837},"obj":"Sentence"},{"id":"T230","span":{"begin":838,"end":969},"obj":"Sentence"},{"id":"T231","span":{"begin":970,"end":1082},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}

{"project":"2_test","denotations":[{"id":"32450171-19475608-66454513","span":{"begin":964,"end":967},"obj":"19475608"}],"text":"S1 is a specific antigen for SARS-CoV-2 diagnostics [98]. The S1 subunit of SARS-CoV or SARS-CoV-2 has four core domains S1A through S1D. The human 47D11 antibody binds the S1B of both viruses, without competing with S1B binding to ACE2 receptor expressed at the cell surface, and showed cross-neutralizing activity by an unknown mechanism that is different from receptor binding interference [99]. An immunogenic domain in the S2 subunit of SARS-CoV S (aa 1029–1192) was highly conserved in several strains of SARS-CoV-2. Four murine monoclonal Abs, 1A9, 1G10, 2B2 and 4B12, against this S2 subunit of SARS-CoV can also cross-reactive with the S protein of SARS-CoV-2. Interestingly, 1A9 can strongly bind the S2 subunit of SARS-CoV-2 through a novel epitope (aa 1111–1130) and can detect S protein in SARS-CoV-2 during infection [100]. This epitope also overlaps with one of two cytotoxic T-lymphocyte epitopes (aa 884–891 and 1116–1123) of SARS-CoV S2 subunit [101]. 1A9 is therefore suggested to induce both humoral and cellular immune responses against SARS-CoV and SARS-CoV-2."}